Aimed at addressing systemic inflammation, National Rosacea Society treatment algorithms take a phenotype-driven approach ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The Aroma Season eye mask is filled with natural flax seeds to offer a slightly compressive, non-toxic remedy and a design ...

Uveal melanoma, which primarily affects Caucasian patients, is the most common primary intraocular tumor in adults2 that most ...

The following is a summary of “Efficacy and safety of topical minocycline preparations for papulopustular rosacea: a ...

Reproxalap is a reactive aldehyde species modulator that seeks to treat ocular discomfort in patients with dry eye disease. The treatment had previously been evaluated by the FDA in 2023 before ...

The FDA is requesting additional data demonstrating the effectiveness of reproxalap on treating ocular symptoms of dry eye. The Food and Drug Administration (FDA) has again issued a Complete ...

According to the FDA, reproxalap did not demonstrate efficacy in treating ocular symptoms of dry eye disease. Aldeyra plans to resubmit the new drug application with new trial data later this year.

Because tretinoin can dry and irritate the skin, you’ll want to lock in hydration and support the skin barrier with a solid ...

According to Aldeyra, the FDA found that the submission “failed to demonstrate efficacy in adequate and well-controlled studies in treating ocular symptoms associated with dry eyes.” ...

The drug has "failed to demonstrate efficacy in adequate and well controlled studies in treating ocular symptoms associated with dry eyes," the FDA wrote, Aldeyra said. The agency told the firm ...